Procter & Gamble Co.
Procter & Gamble Co. (PG) demonstrates moderate business quality and growth, offset by lower scores in financial strength and capital allocation. The company shows consistent revenue and net profit growth, but its valuation metrics suggest it might be overvalued.
Business Performance (CAGR)
Valuation Snapshot
Financial Health
Profitability Metrics
Cash Flow Intelligence
Intrinsic Value
PremiumEstimated Intrinsic Value & DCF Fair Value are available with Premium plans.
AI Business Verdict
Procter & Gamble Co. exhibits a strong track record of revenue and profit growth with robust profitability and cash flow. However, its financial health indicators, particularly the current ratio, and low scores in financial strength and capital allocation warrant attention. The current valuation appears stretched based on intrinsic value calculations.
- Consistent growth in revenue and net profit.
- Strong operating and net profit margins.
- Robust operating cash flow generation.
- Positive EPS CAGR, indicating effective shareholder value creation.
Balance Sheet
Procter & Gamble Co. has an adequate but tight balance sheet — leverage and liquidity warrant monitoring.
Capacity to fund growth, withstand downturns and return capital.
- Procter & Gamble Co.
- has an adequate but tight balance sheet — leverage and liquidity warrant monitoring.
- Balance sheet is functional but shows no standout strengths
- Tight short-term liquidity cushion